Pneumococcal Conjugate Vaccine impact assessment in Bangladesh

The study examines the impact of the introduction of 10-valent Pneumococcal Conjugate Vaccine (PCV10) into Bangladesh’s national vaccine program. PCV10 is administered to children under 1 year-old; the scheduled ages of administration are at 6, 10, and 18 weeks. The study is conducted in ~770,000 po...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Gates Open Res
Κύριοι συγγραφείς: Baqui, Abdullah H., McCollum, Eric D., Saha, Samir K., Roy, Arun K., Chowdhury, Nabidul H., Harrison, Meagan, Hanif, Abu Abdullah Mohammad, Simmons, Nicole, Mahmud, Arif, Begum, Nazma, Ahmed, Salahuddin, Khan, Ahad M., Ahmed, Zabed Bin, Islam, Maksuda, Mitra, Dipak, Quaiyum, Abdul, Chavez, Miguel A., Pervaiz, Farhan, Miele, Catherine H., Schuh, Holly B., Khanam, Rasheda, Checkley, William, Moulton, Lawrence H., Santosham, Mathuram
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: F1000 Research Limited 2018
Θέματα:
Study Protocol
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6030398/
https://ncbi.nlm.nih.gov/pubmed/29984359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/gatesopenres.12805.1
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια